Ribozyme gene therapy for hepatitis C virus infection

Clinical and Diagnostic Virology

Volumn 10, Issue 2-3, 1998, Pages 163-171

  Welch, Peter J ^a   Yei, Soonpin ^a   Barber, Jack R ^a  

^a Immusol Inc   (United States)

Author keywords

Adeno associated viral vector; Adenoviral vector; Gene therapy; HCV gene expression; Hepatitis C virus; Ribozyme

Indexed keywords

ANTIVIRUS AGENT; PROTEINASE INHIBITOR; RIBOZYME; VIRUS VECTOR;

CONFERENCE PAPER; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; RNA REPLICATION; VIRUS MUTATION;

ADENOVIRIDAE; CAPSID; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; HEPACIVIRUS; HEPATITIS C; HUMANS; RNA, CATALYTIC;

HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; RNA VIRUSES;

EID: 0032527497     PISSN: 09280197     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0197(98)00029-4     Document Type: Conference Paper

References (15)

1. Bramson J.L., Graham F.L., Gauldie J. The use of adenoviral vectors for gene therapy and gene transfer in vivo. Curr Opin Biotechnol. 6:1995;590-595.
2. Brown E.A., Zhang H., Ping L.H., Lemon S.M. Secondary structure of the 5′ nontranslated regions of hepatitis C virus and pestivirus genomic RNAs. Nucleic Acids Res. 20:1992;5041-5045.
3. Bukh J., Purcell R.H., Miller R.H. Sequence analysis of 5′ noncoding region of hepatitis C virus. Proc Natl Acad Sci USA. 89:1992;4942-4946.
4. Bukh J., Miller R.H., Purcell R.H. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis. 15:1995;41-63.
5. Cech T.R., Bass B.L. Biological catalysis by RNA. Ann Rev Biochem. 55:1986;599-629.
6. Choo Q.L., Richman K.H., Han J.H., Berger K., Lee C., Dong C., Gallegos C., Coit D., Medina-Selby A., Barr P.J., Weiner A.J., Bradley D.W., Kuo G., Houghton M. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA. 88:1991;2451-2455.
7. Hampel A., Tritz R. RNA catalytic properties of the minimum (-)s TRSV sequence. Biochemistry. 28:1989;4929-4933.
8. Kijima H., Ishida H., Ohkawa T., Kashani-Sabet M., Scanlon K.J. Therapeutic application of ribozymes. Pharmacol Ther. 68:1995;247-267.
9. Mamounas M., Leavitt M., Yu M., Wong-Staal F. Increased titer of recombinant AAV vectors by gene transfer with adenovirus-coupled to DNA-polylysine complexes. Gene Ther. 2:1995;429-432.
10. Muzyczka N. Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr Top Microbiol Immunol. 158:1992;97-123.
11. Ponnazhagan S., Mukherjee P., Yoder M.C., Wang X-S., Zhou S.Z., Kaplan J., Wadsworth S., Srivastava A. Adeno-associated virus 2-mediated gene transfer in vivo: organ tropism and expression of transduced sequences in mice. Gene. 190:1997;203-210.
12. Simmonds P. Variability of hepatitis C virus. Hepatology. 21:1995;570-583.
13. van Doorn L.J. Review: molecular biology of the hepatitis C virus. J Med Virol. 43:1994;345-356.
14. Welch P.J., Tritz R., Yei S., Leavitt M., Yu M., Barber J. A potential therapeutic application of hairpin ribozymes: in vitro and in vivo studies of gene therapy for hepatitis C virus infection. Gene Ther. 3:1996;994-1001.
15. Wilson J. Adenovirus-mediated gene transfer to liver. Adv Drug Deliv Rev. 17:1995;303-307.